Plasma exchange in myasthenia gravis. 1984

G Marconi, and S Bobbi, and A Pizzi, and C Sbrilli, and R Taiuti, and O Ronchi, and G Avanzi, and R Lombardo, and C Franco, and D Biani

Results obtained with P.E. therapy on 19 myasthenic patients are reported. 15 of them improved during treatment and 4 remained unchanged. We believe P.E. is an useful therapy in M.G. because it produces a rapid improvement in most patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G Marconi, and S Bobbi, and A Pizzi, and C Sbrilli, and R Taiuti, and O Ronchi, and G Avanzi, and R Lombardo, and C Franco, and D Biani
April 1998, The International journal of artificial organs,
G Marconi, and S Bobbi, and A Pizzi, and C Sbrilli, and R Taiuti, and O Ronchi, and G Avanzi, and R Lombardo, and C Franco, and D Biani
December 1982, Der Nervenarzt,
G Marconi, and S Bobbi, and A Pizzi, and C Sbrilli, and R Taiuti, and O Ronchi, and G Avanzi, and R Lombardo, and C Franco, and D Biani
February 1977, Lancet (London, England),
G Marconi, and S Bobbi, and A Pizzi, and C Sbrilli, and R Taiuti, and O Ronchi, and G Avanzi, and R Lombardo, and C Franco, and D Biani
January 1977, Lancet (London, England),
G Marconi, and S Bobbi, and A Pizzi, and C Sbrilli, and R Taiuti, and O Ronchi, and G Avanzi, and R Lombardo, and C Franco, and D Biani
January 2002, The Cochrane database of systematic reviews,
G Marconi, and S Bobbi, and A Pizzi, and C Sbrilli, and R Taiuti, and O Ronchi, and G Avanzi, and R Lombardo, and C Franco, and D Biani
October 1981, [Rinsho ketsueki] The Japanese journal of clinical hematology,
G Marconi, and S Bobbi, and A Pizzi, and C Sbrilli, and R Taiuti, and O Ronchi, and G Avanzi, and R Lombardo, and C Franco, and D Biani
December 1981, Revue francaise de transfusion et immuno-hematologie,
G Marconi, and S Bobbi, and A Pizzi, and C Sbrilli, and R Taiuti, and O Ronchi, and G Avanzi, and R Lombardo, and C Franco, and D Biani
November 1985, Acta neurologica Scandinavica,
G Marconi, and S Bobbi, and A Pizzi, and C Sbrilli, and R Taiuti, and O Ronchi, and G Avanzi, and R Lombardo, and C Franco, and D Biani
December 1980, Annals of neurology,
G Marconi, and S Bobbi, and A Pizzi, and C Sbrilli, and R Taiuti, and O Ronchi, and G Avanzi, and R Lombardo, and C Franco, and D Biani
December 1976, Lancet (London, England),
Copied contents to your clipboard!